Combining chronic kidney disease with thallium/iodine β methyliodophenyl pentadecanoic acid dual myocardial single-photon emission computed tomography findings is useful for the evaluation of cardiac event risk

Nuclear Medicine Communications

Volumn 30, Issue 1, 2009, Pages 54-61

  Takamura, Takeshi ^a   Takahashi, Nobukazu ^a   Ishigami, Tomoaki ^a   Sugano, Teruyasu ^a   Ishikawa, Toshiyuki ^a   Uchino, Kazuaki ^a   Kimura, Kazuo ^a   Inoue, Tomio ^a   Umemura, Satoshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Chronic kidney disease; Coronary artery disease; Prognosis; Thallium 201

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; THALLIUM 201;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HEART DEATH; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; UNSTABLE ANGINA PECTORIS;

AGED; CHRONIC DISEASE; FATTY ACIDS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART; HEART DISEASES; HUMANS; IODOBENZENES; KAPLAN-MEIERS ESTIMATE; KIDNEY DISEASES; MALE; MULTIVARIATE ANALYSIS; MYOCARDIUM; PROGNOSIS; RISK; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 57749168410     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328314b879     Document Type: Article

References (35)

1. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998; 97:535-543.
2. Marie PY, Danchin N, Durand JF, Feldmann L, Grentzinger A, Olivier P, et al. Long-term prediction of major ischemic events by exercise thallium-201 single-photon emission computed tomography. Incremental prognostic value compared with clinical, exercise testing, catheterization and radionuclide angiographic data. J Am Coll Cardiol 1995; 26:879-886.
3. Miller TD, Christian TF, Hodge DO, Mullan BP, Gibbons RJ. Prognostic value of exercise thallium-201 imaging performed within 2 years of coronary artery bypass graft surgery. J Am Coll Cardiol 1998; 31:848-854.
4. Yamabe H, Abe H, Yokoyama M, Shiotani H, Kajiya S, Mori T, et al. Resting 123I-BMIPP scintigraphy in diagnosis of effort angina pectoris with reference to subsets of the disease. Ann Nucl Med 1998; 12:139-144.
5. Yamabe H, Fujiwara S, Rin K, Ando M, Yokoyama M, Sakamoto T, et al. Resting 123I-BMIPP scintigraphy for detection of organic coronary stenosis and therapeutic outcome in patients with chest pain. Ann Nucl Med 2000; 14:187-192.
6. Kawai Y, Tsukamoto E, Nozaki Y, Morita K, Sakurai M, Tamaki N. Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain. J Am Coll Cardiol 2001; 38:1888-1894.
7. Chikamori T, Fujita H, Nanasato M, Toba M, Nishimura T. Prognostic value of I-123 15-(p-iodophenyl)-3-(R, S) methylpentadecanoic acid myocardial imaging in patients with known or suspected coronary artery disease. J Nucl Cardiol 2005; 12:172-178.
8. Tawarahara K, Kurata C, Taguchi T, Aoshima S, Okayama K, Kobayashi A, et al. Simultaneous dual myocardial imaging with iodine-123-beta-methyl iodophenyl-pentadecanoic acid (BMIPP) and thallium-201 in patients with coronary heart disease. Jpn Circ J 1994; 58:107-115.
9. Iwasawa H, Abe M, Abe T, Nagai Y, Ibukiyama C. Serial change of Tl/BMIPP dual SPECT myocardial scintigram in patients with acute myocardial infarction; meaning of chronic mismatch phenomenon. Kaku Igaku 1999; 36:349-355.
10. Ix JH, Shipak MG, Brandenburg VM, Ali S, Ketteler M, Whooley MA. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). Am Heart J 2005; 149:512-519.
11. Freeman RV, Metha RH, AI Badr W, Cooper JV, Kline-Rogers E, Eagle KA, et al. Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors. J Am Coll Cardiol 2003; 41:718-724.
12. Ninomiya T, Kiyohara Y. (Chronic kidney diseases and other diseases: 1. Cardiovascular diseases). Nippon Naika Gakkai Zasshi 2007; 96:887-893.
13. Hostetter TH. Chronic kidney disease predicts cardiovascular disease. N Engl J Med 2004; 351:1344-1346.
14. Wattanakit K, Coresh J, Munter P, Marsh J, Folsom AR. Cardiovascular risk among adults with chronic kidney disease, with or without prior myocardial infarction. J Am Coll Cardiol 2006; 48:1183-1189.
15. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
16. Meisinger C, Doring A, Lowel H. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur Heart J 2006; 27:1245-1250.
17. Landenheim ML, Pollock BH, Rozanski A, Berman DS, Staniloff HM, Forrester JS, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 1986; 7:464-471.
18. Staniloff HM, Forrester JS, Berman DS, Swan HJC. Predictor of death, myocardial infarction, and worsening chest pain using thallium scintigraphy and exercise electrocardiography. J Nucl Med 1986; 27:1842-1848.
19. Zimmermann R, Mall G, Rauch B, Zimmer G, Gabel M, Zehelein J, et al. Residual Tl activity in irreversible defects as a marker of myocardial viability: clinicopsthological study. Circulation 1995; 91:1016-1021.
20. 201Tl uptake in chronically hypoperfused myocardium: histologic correlation study. J Nucl Med 2000; 41:293-296.
21. Schiller NB, Shah PM, Crawford M, deMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantification of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367.
22. National Kidney Foundation. Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kid Dis 2002; 2 (Suppl 1):S46-S75.
23. Gillium RF, Fortmann SP, Prineas RJ, Kottke TE. International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J 1984; 108:150-158.
24. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971; 285:1441-1446.
25. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheithlin MD, Hochman JS. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002. Circulation 2002; 106:1893-1900.
26. Berman DS, Kang X, Van Train KF, Lewin HC, Cohen I, Areeda J, et al. Comparative prognostic value of autonomic quantitative analysis versus semiquantitative visual analysis of exercise myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1998; 32:1987-1995.
27. Keith DS, Nicholas GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164:659-663.
28. Stewart RE, Dickinson CZ, Weismann IA, O'Neill WW, Dworkin HJ, Juni JE. Clinical outcome of patients evaluated with emergency center myocardial perfusion SPECT for unexplained chest pain. Nucl Med Commun 1996; 17:459-462.
29. Tatum JL, Jesse RL, Kontos MC, Nicholson CS, Schmidt KL, Roberts CS. Comprehensive strategy for the evaluation and triage of the chest pain patients. Ann Emerg Med 1997; 29:116-125.
30. Heller GV, Stowers SA, Hendel RC, Herman SD, Daher E, Ahlberg AW, et al. Clinical value of acute rest technetium-99m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and nondiagnostic electrocardiograms. J Am Coll Cardiol 1998; 31:1011-1017.
31. Schwaiger M, Schelbert HR, Ellison D, Hansen H, Yeatman L, Vinten-Johansen J, et al. Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J Am Coll Cardiol 1985; 6:336-347.
32. Matsuki T, Tamaki N, Nakata T, Doi A, Takahashi H, Iwata M, et al. Prognostic value of fatty acid imaging in patients with angina pectoris without prior myocardial infarction: comparison with stress thallium imaging. Eur J Nucl Med Mol Imaging 2004; 31:1585-1591.
33. Hashimoto A, Nakata T, Tamaki N, Kobayashi T, Matsuki T, Shogase T, et al. Serial alterations and prognostic implications of myocardial perfusion and fatty acid metabolism in patients with acute myocardial infarction. Circ J 2006; 70:1466-1474.
34. Foley RN, Parfrey PS, Samak MJ. Clinical epidermology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32 (5 Suppl 3):S112-S119.
35. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from global outcomes (KDIGO). Kidney Int 2005; 67:2089-2100.